Dergiler / Turkish journal of vascular surgery / 2021 / Cilt: 30 - Sayı: 1

The use of CO2 angiography in the treatment of peripheral arterial disease: Our initial experience

Sayfa
35–41
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Our study results show that CO2-DSA can be used as an affordable and effective alternative in the diagnosis and treatment of peripheral arterial disease with contraindications for iodinated contrast material

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: In this study, we present our initial experience in the use of carbon dioxide (CO2) digital subtraction angiography (DSA) for the treatment of peripheral arterial disease.
📊
Temel Bulgular & Veri:Patients and methods: This retrospective study included a total of six male patients (mean age 63.5±6.9 years; range, 56 to 72 years) with Rutherford Stage 3-4 who were high-risk for chronic renal failure and underwent percutaneous transluminal angioplasty (PTA) due to iliac or femoropopliteal lesions using CO2-DSA between October 2018 and January 2020.
💡
Sonuç & Katkı:Conclusion: Our study results show that CO2-DSA can be used as an affordable and effective alternative in the diagnosis and treatment of peripheral arterial disease with contraindications for iodinated contrast material
🔬Tür:Araştırma Makalesi
📍Kapsam:2018 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: In this study, we present our initial experience in the use of carbon dioxide (CO2) digital subtraction angiography (DSA) for the treatment of peripheral arterial disease. Patients and methods: This retrospective study included a total of six male patients (mean age 63.5±6.9 years; range, 56 to 72 years) with Rutherford Stage 3-4 who were high-risk for chronic renal failure and underwent percutaneous transluminal angioplasty (PTA) due to iliac or femoropopliteal lesions using CO2-DSA between October 2018 and January 2020. Demographic and clinical characteristics of the patients, ankle-brachial index (ABI) values, and technical success rate were evaluated. Results: No contrast medium was used in any of the procedure. Technical success rate was 100% and no intraoperative complication was observed. All patients had a non-significant increase in the creatinine levels during follow-up (p=0.076). There was a significant difference between the pre- and postoperative ABI values (p=0.028). All patients were followed in the wards after the procedure and were discharged on postoperative Day 1 with symptomatic recovery. Conclusion: Our study results show that CO2-DSA can be used as an affordable and effective alternative in the diagnosis and treatment of peripheral arterial disease with contraindications for iodinated contrast material

🔖

Bu Makaleye Atıf Yap

YİĞİT, G., ÇETİNKAYA, F., ÖZEN, A., İŞCAN, H. Z., ÜNAL, E. U., YILMAZ, M., TÜMER, N. B. (2022). The use of CO2 angiography in the treatment of peripheral arterial disease: Our initial experience. Turkish journal of vascular surgery, Cilt: 30 - Sayı: 1, 35–41. https://ajindex.com/articles/614490

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II. J Vasc Surg 2011;53:992-9
  2. Hall KA, Wong RW, Hunter GC, Camazine BM, Rappaport WA, Smyth SH, et al. Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 1992;53:317-20
  3. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989;320:143-9
  4. Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res 2006;29:84-93
  5. Arinze NV, Gregory A, Francis JM, Farber A, Chitalia VC. Unique aspects of peripheral artery disease in patients with chronic kidney disease. Vasc Med 2019;24:251-60
  6. Nadolski GJ, Stavropoulos SW. Contrast alternatives for iodinated contrast allergy and renal dysfunction: options and limitations. J Vasc Surg 2013;57:593-8
  7. Moos JM, Ham SW, Han SM, Lew WK, Hua HT, Hood DB, et al. Safety of carbon dioxide digital subtraction angiography. Arch Surg 2011;146:1428-32
  8. Cho KJ. Carbon dioxide angiography: Scientific principles and practice. Vasc Specialist Int 2015;31:67-80
  9. Hawkins IF, Cho KJ, Caridi JG. Carbon dioxide in angiography to reduce the risk of contrast-induced nephropathy. Radiol Clin North Am 2009;47:813-25
  10. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38
  11. Giordano A, Messina S, Polimeno M, Corcione N, Ferraro P, Biondi-Zoccai G, et al. Peripheral diagnostic and interventional procedures using an automated injection system for carbon dioxide (CO2): case series and learning curve. Heart Lung Vessel 2015;7:18-26
  12. Yiğit G, Sarıcaoğlu MC, Çetinkaya F, Özen A, İşcan HZ. Endovascular treatment of chronic total occlusion of iliac/ femoral arteries: Mid-term follow-up. Turk J Vasc Surg 2020;29:7-12
  13. Walsh SR, Tang TY, Boyle JR. Renal consequences of endovascular abdominal aortic aneurysm repair. J Endovasc Ther 2008;15:73-82
  14. Hawkins IF. Carbon dioxide digital subtraction arteriography. AJR Am J Roentgenol 1982;139:19-24
  15. Koutouzi G, Henrikson O, Roos H, Zachrisson K, Falkenberg M. EVAR Guided b